Electrophysiologic Measures of Treatment Response in Alzheimer Disease
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the electrophysiological effects of
cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer
disease. The attempt will be to locate electrophysiological markers and predictors of
cognitive and clinical treatment response.
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development